Company: TVRD
Filing Date: 2025-10-20
Form Type: S-1/A
Source: 0001104659-25-100896
Chunk: 289

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-1/A
Chunk 289
---
 stock covered by this prospectus. The percentage of beneficial ownership after the offered shares of common stock are sold is calculated based on based on 9,373,433 shares of our common stock outstanding as of June 30, 2025. We have determined beneficial ownership in accordance with the rules of the SEC and the information is not necessarily indicative of beneficial ownership for any other purpose. Unless otherwise indicated below, to our knowledge, the persons and entities named in the tables have sole voting and sole investment power with respect to the shares of common stock set forth below, subject to community property laws where applicable. We cannot advise you as to whether the selling stockholders will in fact sell any or all of such common stock. In addition, the selling stockholders may sell, transfer or otherwise dispose of, at any time and from time to time, the common stock offered hereby in transactions exempt from the registration requirements of the Securities Act after the date of this prospectus. For purposes of this table, we have assumed that the selling stockholders will have sold all of the shares of common stock covered by this prospectus upon the completion of the offering. Selling stockholder information for each additional selling stockholder, if any, will be set forth by a prospectus supplement to the extent required prior to the time of any offer or sale of such selling stockholder’s shares pursuant to this prospectus. Any prospectus supplement may add, update, substitute, or change the information contained in this prospectus, including the identity of each selling stockholder and the number of shares registered on its behalf. A selling stockholder may sell or otherwise transfer all, some or none of such shares in this offering. See “ Plan of Distribution .” Unless otherwise indicated, the address for the following selling stockholders is: c/o Tvardi Therapeutics, Inc., 3 Sugar Creek Ctr Blvd, Ste 525, Sugar Land, TX 77478.

| Name of Selling stockholder              | ​      | ​ | CommonStockBeneficiallyOwnedPrior toOffering |   |           |   | ​       | ​ | Number ofShares ofCommonStock BeingOffered |   |           |   | ​ | ​ | Common StockBeneficiallyOwned After theOffered Shares ofCommon Stockare Sold |   |       |   |   |   |   |   |   |   | ​ |
| ​                                        | Number |   |                                              |   |         ​ | ​ | Percent |   |                                            |   |         ​ |   |